Ondine Biomedical (FRA:VF5) EPS (Basic) : €-0.04 (TTM As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Ondine Biomedical EPS (Basic)?

Ondine Biomedical's basic earnings per share (Basic EPS) for the six months ended in Jun. 2024 was €-0.02. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.04.

Ondine Biomedical's EPS (Diluted) for the six months ended in Jun. 2024 was €-0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.04.

Ondine Biomedical's EPS without NRI for the six months ended in Jun. 2024 was €-0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2024 was -0.04.

During the past 3 years, the average EPS without NRI Growth Rate was 4.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was -3.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was 11.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Ondine Biomedical's highest 3-Year average EPS without NRI Growth Rate was 53.20% per year. The lowest was -157.10% per year. And the median was -3.20% per year.

Ondine Biomedical EPS (Basic) Historical Data

The historical data trend for Ondine Biomedical's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ondine Biomedical EPS (Basic) Chart

Ondine Biomedical Annual Data

Trend

Dec08

Dec09

Dec10

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

-0.05

-0.44

-0.07

-0.05

Ondine Biomedical Semi-Annual Data
	Dec07	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EPS (Basic)	Get a 7-Day Free Trial															-0.03	-0.04	-0.03	-0.02	-0.02

Ondine Biomedical EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Ondine Biomedical's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-9.851	-	0)	/	197.112
	=	-0.05

Ondine Biomedical's Basic EPS for the quarter that ended in Jun. 2024 is calculated as

Basic EPS (Q: Jun. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-5.262	-	0)	/	241.469
	=	-0.02

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.04

Ondine Biomedical (FRA:VF5) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Ondine Biomedical EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Ondine Biomedical's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Ondine Biomedical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ondine Biomedical Inc (FRA:VF5) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

OBI:UK

Address

1100 Melville Street, Suite 888, Vancouver, BC, CAN, V6E4A6

Website

https://www.ondinebio.com

Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.

Ondine Biomedical Headlines

No Headlines